Cases & Deals

Celgene announces $2.9 billion acquisition of Pharmion

Clients Celgene Corporation

Jones Day advised Celgene Corporation in its $2.9 billion acquisition of Pharmion. In the merger, Pharmion shareholders received in exchange for their stock, Celgene stock and cash.